Groupe Hospitalier Saint Vincent
- Address
- 182 Route De La Wantzenau, 67000 STRASBOURG, Alsace, France
Oncology at Groupe Hospitalier Saint Vincent
The clinical research program here focuses on cancer care, with studies spanning prostate cancer, breast cancer, liver cancer, and endometrial cancer. These trials are designed to test new treatment strategies, improve outcomes for patients with advanced or high-risk disease, and refine how therapy is selected in routine oncology practice.
- Research in metastatic breast cancer is evaluating how blood-based tumor markers may help guide treatment choices and identify patients most likely to benefit from targeted therapy.
- Several studies in prostate cancer are comparing new hormonal and immune-based approaches to improve survival and delay disease progression in both metastatic and high-risk localized settings.
- Trials in hepatocellular carcinoma are assessing combination treatment strategies to strengthen first-line cancer control and improve response rates.
- The site is also involved in endometrial cancer research, including work on maintenance treatment after surgery and chemoradiation to reduce the chance of recurrence.
Overall, the portfolio at Groupe Hospitalier Saint Vincent reflects a strong emphasis on precision oncology, with attention to both advanced disease and earlier-stage patients needing better risk-adapted treatment.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 therapeutic areas and 15 of 20 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Groupe Hospitalier Saint Vincent
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-641) | Merck Sharp & Dohme LLC | Phase III | Not Recruiting | Aug 2019 | Aug 2025 |
IMP list
lock Showing 1 of 20 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Alpelisib | 2 | Unknown | 2023-06-06 | 2023-10-19 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.